PLUS1
Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 91.08 ▲ 0.11 (0.12%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.21 | -0.23% | 90.97 | 91.63 | 90.86 | 91.39 | 91.18 | 19:35:41 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 55,371 | 9,667,954 | $ 91.21 | $ 881,819,721 | 8,024,423 | 72.05 - 92.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:26:25 | formt | 114 | $ 91.08 | USD |
Merck Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 231.61B | 2.55B | $ 6.22B | 2.32 | 25.50 | 2.54B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 25.15M | $ 1.99 | 2.19% | 12/13/19 | - | - |
Merck News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/18/2020 | 09:00 | PR Newswire (US) | Significant Study on Veterinary Wellbeing Reveals Importance.. |
| 1/16/2020 | 08:34 | Business Wire | Merck Completes Acquisition of ArQule |
| 1/15/2020 | 17:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 1/13/2020 | 07:43 | Dow Jones News | AstraZeneca, Merck Get FDA Priority Review for Lynparza in.. |
| 1/13/2020 | 06:55 | Business Wire | FDA Accepts Regulatory Submission of Supplemental New Drug.. |
| 1/13/2020 | 06:30 | GlobeNewswire Inc. | BriaCell Provides Update on Remarkable Responder |
| 1/10/2020 | 18:33 | Dow Jones News | Bristol-Myers Squibb, Macy's, Grubhub: Stocks That Defined.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 89.66 | 92.0554 | 88.87 | 90.36 | 7,959,446 | 1.31 | 1.46% |
| 1 Month | 91.46 | 92.64 | 88.40 | 90.51 | 7,524,106 | -0.49 | -0.54% |
| 3 Months | 82.19 | 92.64 | 80.34 | 87.40 | 8,223,697 | 8.78 | 10.68% |
| 6 Months | 81.96 | 92.64 | 78.85 | 85.42 | 8,221,281 | 9.01 | 10.99% |
| 1 Year | 74.31 | 92.64 | 72.05 | 82.20 | 9,451,217 | 16.66 | 22.42% |
| 3 Years | 61.92 | 92.64 | 52.83 | 69.59 | 9,606,390 | 29.05 | 46.92% |
| 5 Years | 62.71 | 92.64 | 45.69 | 64.56 | 9,521,004 | 28.26 | 45.06% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States. |
